Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2009

01.07.2009 | Original Paper

Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI

verfasst von: Akihiko Matsumine, K. Kusuzaki, T. Nakamura, S. Nakazora, R. Niimi, T. Matsubara, K. Uchida, T. Murata, I. Kudawara, T. Ueda, N. Naka, N. Araki, M. Maeda, A. Uchida

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The imaging discrimination between neurofibroma (NF) and malignant peripheral nerve sheath tumor (MPNST) is clinically very important. The purpose of this study is to define the criteria for the differential diagnosis between NF and MPNST on MRI in neurofibromatosis 1 (NF1).

Methods

A total of 37 patients with NF1, 18 NFs and 19 MPNSTs were evaluated by MRI at 1.5 T. Magnetic resonance imaging (MRI) findings were compared using univariate and multivariate analyses.

Results

The MRI findings characteristic of MPNST (p < 0.05) were an irregular tumor shape (15/19 in MPNST vs. 5/18 in NF), unclear margin (13/19 in MPNST vs. 6/18 in NF), intra-tumoral lobulation (12/19 in MPNST vs. 3/18 in NF), presence of high signal-intensity area on T1-weighted images (T1WI) (12/19 in MPNST vs. 1/18 in NF), no target sign (0/19 in MPNST vs. 12/18 in NF), inhomogeneous enhancement on contract-enhanced T1WI (17/18 in MPNST vs. 9/16 in NF) and a lower rate of enhanced area (54% in MPNST vs. 87% in NF) were critical indicators to differentiate MPNST from NF. A multivariate analysis showed that intra-tumoral lobulation and the presence of a high signal-intensity area on T1WI were considered to be diagnostic indicators of MPNST. The sensitivity and specificity for these two items were 63.2, 83.3, 63.2 and 87.5%, respectively.

Conclusion

MRI shows features which were helpful for differentiating MPNST from NF.
Literatur
Zurück zum Zitat Bass JC, Korobkin M, Francis IR, Ellis JH, Cohan RH (1994) Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 163:617–620PubMed Bass JC, Korobkin M, Francis IR, Ellis JH, Cohan RH (1994) Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 163:617–620PubMed
Zurück zum Zitat Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27:124–129. doi:10.1007/s002470050082 PubMedCrossRef Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD (1997) MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol 27:124–129. doi:10.​1007/​s002470050082 PubMedCrossRef
Zurück zum Zitat Cardona S, Schwarzbach M, Hinz U, Dimitrakopoulou-Strauss A, Attigah N, Mechtersheimer section sign G, Lehnert T (2003) Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol 29:536–541. doi:10.1016/S0748-7983(03)00055-6 PubMedCrossRef Cardona S, Schwarzbach M, Hinz U, Dimitrakopoulou-Strauss A, Attigah N, Mechtersheimer section sign G, Lehnert T (2003) Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol 29:536–541. doi:10.​1016/​S0748-7983(03)00055-6 PubMedCrossRef
Zurück zum Zitat Coleman BG, Arger PH, Dalinka MK, Obringer AC, Raney BR, Meadows AT (1983) CT of sarcomatous degeneration in neurofibromatosis. AJR Am J Roentgenol 140:383–387PubMed Coleman BG, Arger PH, Dalinka MK, Obringer AC, Raney BR, Meadows AT (1983) CT of sarcomatous degeneration in neurofibromatosis. AJR Am J Roentgenol 140:383–387PubMed
Zurück zum Zitat Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581–586PubMed Crim JR, Seeger LL, Yao L, Chandnani V, Eckardt JJ (1992) Diagnosis of soft-tissue masses with MR imaging: can benign masses be differentiated from malignant ones? Radiology 185:581–586PubMed
Zurück zum Zitat Ferner RE, Lucas JD, O’Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J (2000) Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68:353–357. doi:10.1136/jnnp.68.3.353 PubMedCrossRef Ferner RE, Lucas JD, O’Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J (2000) Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68:353–357. doi:10.​1136/​jnnp.​68.​3.​353 PubMedCrossRef
Zurück zum Zitat Fortman BJ, Kuszyk BS, Urban BA, Fishman EK (2001) Neurofibromatosis type 1: a diagnostic mimicker at CT. Radiographics 21:601–612PubMed Fortman BJ, Kuszyk BS, Urban BA, Fishman EK (2001) Neurofibromatosis type 1: a diagnostic mimicker at CT. Radiographics 21:601–612PubMed
Zurück zum Zitat Jee WH, Oh SN, McCauley T, Ryu KN, Suh JS, Lee JH, Park JM, Chun KA, Sung MS, Kim K, Lee YS, Kang YK, Ok IY, Kim JM (2004) Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol 183:629–633PubMed Jee WH, Oh SN, McCauley T, Ryu KN, Suh JS, Lee JH, Park JM, Chun KA, Sung MS, Kim K, Lee YS, Kang YK, Ok IY, Kim JM (2004) Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol 183:629–633PubMed
Zurück zum Zitat King AA, DeBaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388–392. doi:10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#PubMedCrossRef King AA, DeBaun MR, Riccardi VM, Gutmann DH (2000) Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 93:388–392. doi:10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#PubMedCrossRef
Zurück zum Zitat Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31–37. doi:10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-WPubMedCrossRef Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31–37. doi:10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-WPubMedCrossRef
Zurück zum Zitat Kransdorf MJ, Jelinek JS, Moser RP Jr, Utz JA, Brower AC, Hudson TM, Berrey BH (1989) Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 153:541–547PubMed Kransdorf MJ, Jelinek JS, Moser RP Jr, Utz JA, Brower AC, Hudson TM, Berrey BH (1989) Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol 153:541–547PubMed
Zurück zum Zitat Kumar AJ, Kuhajda FP, Martinez CR, Fishman EK, Jezic DV, Siegelman SS (1983) Computed tomography of extracranial nerve sheath tumors with pathological correlation. J Comput Assist Tomogr 7:857–865PubMedCrossRef Kumar AJ, Kuhajda FP, Martinez CR, Fishman EK, Jezic DV, Siegelman SS (1983) Computed tomography of extracranial nerve sheath tumors with pathological correlation. J Comput Assist Tomogr 7:857–865PubMedCrossRef
Zurück zum Zitat Lawrence W Jr, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D (1987) Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg Apr 205:349–359 Lawrence W Jr, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D (1987) Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg Apr 205:349–359
Zurück zum Zitat Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 149:1059–1064PubMed Levine E, Huntrakoon M, Wetzel LH (1987) Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 149:1059–1064PubMed
Zurück zum Zitat Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Fünsterer C (2003) Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45:618–625. doi:10.1007/s00234-003-0964-6 PubMedCrossRef Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knöfel MT, Wenzel R, Fünsterer C (2003) Malignant peripheral nerve sheath tumours in neurofibromatosis type 1: MRI supports the diagnosis of malignant plexiform neurofibroma. Neuroradiology 45:618–625. doi:10.​1007/​s00234-003-0964-6 PubMedCrossRef
Zurück zum Zitat McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197–203PubMed McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197–203PubMed
Zurück zum Zitat Anonymous (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578 Anonymous (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578
Zurück zum Zitat Otsuka H, Graham MM, Kubo A, Nishitani H (2005) FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report. Ann Nucl Med 19:55–58PubMedCrossRef Otsuka H, Graham MM, Kubo A, Nishitani H (2005) FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report. Ann Nucl Med 19:55–58PubMedCrossRef
Zurück zum Zitat Sakai F, Sone S, Kiyono K, Maruyama A, Ueda H, Aoki J, Kawai T, Ishii K, Morimoto M, Haniuda M et al (1992) Intrathoracic neurogenic tumors: MR-pathologic correlation. AJR Am J Roentgenol 159:279–283PubMed Sakai F, Sone S, Kiyono K, Maruyama A, Ueda H, Aoki J, Kawai T, Ishii K, Morimoto M, Haniuda M et al (1992) Intrathoracic neurogenic tumors: MR-pathologic correlation. AJR Am J Roentgenol 159:279–283PubMed
Zurück zum Zitat van der Woude HJ, Verstraete KL, Hogendoorn PC, Taminiau AH, Hermans J, Bloem JL (1998) Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology 208:821–828PubMed van der Woude HJ, Verstraete KL, Hogendoorn PC, Taminiau AH, Hermans J, Bloem JL (1998) Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? Radiology 208:821–828PubMed
Zurück zum Zitat Weisss SW, Goldbulum JR (2008) Malignant tumors of the perioheral nerves. In: Weisss SW, Goldbulum JR (eds) Enzinger and Weiss’s soft tissue tumors, 5th edn. Elsevier, Netherlands, pp 903–944 Weisss SW, Goldbulum JR (2008) Malignant tumors of the perioheral nerves. In: Weisss SW, Goldbulum JR (eds) Enzinger and Weiss’s soft tissue tumors, 5th edn. Elsevier, Netherlands, pp 903–944
Metadaten
Titel
Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI
verfasst von
Akihiko Matsumine
K. Kusuzaki
T. Nakamura
S. Nakazora
R. Niimi
T. Matsubara
K. Uchida
T. Murata
I. Kudawara
T. Ueda
N. Naka
N. Araki
M. Maeda
A. Uchida
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2009
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0523-y

Weitere Artikel der Ausgabe 7/2009

Journal of Cancer Research and Clinical Oncology 7/2009 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.